Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure

International Journal of Cardiology

Volumn 261, Issue , 2018, Pages 114-118

  Nakano, Hiroki ^a,d   Nagai, Toshiyuki ^a,b,e   Sundaram, Varun ^a,b,c,f,g   Nakai, Michikazu ^a   Nishimura, Kunihiro ^a   Honda, Yasuyuki ^a   Honda, Satoshi ^a   Iwakami, Naotsugu ^a   Sugano, Yasuo ^a   Asaumi, Yasuhide ^a   Aiba, Takeshi ^a   Noguchi, Teruo ^a   Kusano, Kengo ^a   Yokoyama, Hiroyuki ^a   Ogawa, Hisao ^a   Yasuda, Satoshi ^a   Chikamori, Taishiro ^d   Anzai, Toshihisa ^a,e  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Hospitalized heart failure; Iron deficiency; Prognosis

Indexed keywords

FERRITIN; TRANSFERRIN;

AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; BLOOD; COHORT ANALYSIS; FOLLOW UP; HOSPITALIZATION; IRON DEFICIENCY ANEMIA; METABOLISM; MORTALITY; PROSPECTIVE STUDY; REGISTER; TIME FACTOR; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; COHORT STUDIES; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; PROSPECTIVE STUDIES; REGISTRIES; TIME FACTORS; TRANSFERRIN; TREATMENT OUTCOME;

EID: 85044277176     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2018.03.039     Document Type: Article

References (26)

1. Wong, C.Y., Chaudhry, S.I., Desai, M.M., et al. Trends in comorbidity, disability, and polypharmacy in heart failure. Am. J. Med. 124 (2011), 136–143.
2. Cohen-Solal, A., Leclercq, C., Deray, G., et al. Iron deficiency: an emerging therapeutic target in heart failure. Heart 100 (2014), 1414–1420.
3. Ponikowski, P., Voors, A.A., Anker, S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18 (2016), 891–975.
4. Writing Committee M, Yancy, C.W., Jessup, M., et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128 (2013), e240–327.
5. Cohen-Solal, A., Damy, T., Terbah, M., et al. High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur. J. Heart Fail. 16 (2014), 984–991.
6. Nunez, J., Comin-Colet, J., Minana, G., et al. Iron deficiency and risk of early readmission following a hospitalization for acute heart failure. Eur. J. Heart Fail. 18 (2016), 798–802.
7. Nagai, T., Nishimura, K., Honma, T., et al. Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure. Eur. J. Heart Fail. 18 (2016), 803–813.
8. Finch, C.A., Miller, L.R., Inamdar, A.R., et al. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J. Clin. Invest. 58 (1976), 447–453.
9. Dong, F., Zhang, X., Culver, B., et al. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin. Sci. (Lond.) 109 (2005), 277–286.
10. Maeder, M.T., Khammy, O., dos Remedios, C., et al. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J. Am. Coll. Cardiol. 58 (2011), 474–480.
11. Jankowska, E.A., von Haehling, S., Anker, S.D., et al. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur. Heart J. 34 (2013), 816–829.
12. Hughes, C.M., Woodside, J.V., McGartland, C., et al. Nutritional intake and oxidative stress in chronic heart failure. Nutr. Metab. Cardiovasc. Dis. 22 (2012), 376–382.
13. Naito, Y., Tsujino, T., Fujimori, Y., et al. Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats. J. Hypertens. 29 (2011), 741–748.
14. Franchini, M., Montagnana, M., Lippi, G., Hepcidin and iron metabolism: from laboratory to clinical implications. Clin. Chim. Acta 411 (2010), 1565–1569.
15. Handelman, G.J., Levin, N.W., Iron and anemia in human biology: a review of mechanisms. Heart Fail. Rev. 13 (2008), 393–404.
16. Kemna, E.H., Tjalsma, H., Willems, H.L., et al. Hepcidin: from discovery to differential diagnosis. Haematologica 93 (2008), 90–97.
17. Dallalio, G., Law, E., Means, R.T. Jr., Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 107 (2006), 2702–2704.
18. Klip, I.T., Jankowska, E.A., Enjuanes, C., et al. The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences. Eur. J. Heart Fail. 16 (2014), 655–662.
19. Ponikowski, P., Filippatos, G., Colet, J.C., et al. The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. Eur. J. Heart Fail. 17 (2015), 329–339.
20. Beard, J.L., Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr., 131, 2001, 568S-79S.
21. Fairbanks, V.B.E., Iron deficiency. Beutler, E., (eds.), 6th ed. Williams Hematology, 295–304, 2001, McGraw-Hill, New York, 447–470.
22. Jankowska, E.A., Rozentryt, P., Witkowska, A., et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur. Heart J. 31 (2010), 1872–1880.
23. Haas, J.D., Brownlie, Tt, Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J. Nutr., 131, 2001, 676S-88S.
24. Varma, A., Appleton, D.L., Nusca, A., et al. Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting. Minerva Cardioangiol. 58 (2010), 1–10.
25. Anker, S.D., Comin Colet, J., Filippatos, G., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 361 (2009), 2436–2448.
26. Ponikowski, P., van Veldhuisen, D.J., Comin-Colet, J., et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency dagger. Eur. Heart J. 36 (2015), 657–668.